The third variable loop (V3) of gp120 is a promising AIDS vaccine target because it mediates HIV-1’s contact with coreceptors CCR4 or CXCR5 (1, 2). It is very immunogenic and readily accessible to antibodies (3). Passive immunization with anti-V3 antibodies also shows protection in nonhuman primate studies (4, 5). V3 is generally 35 amino acids in length, beginning with disulfide bond between Cys at position 296 (Cys296) and Cys331 (HXB2 numbering (6)). It can be divided into three structural regions: the disulfide linkage at the base in the gp120 core, the distal crown region of about 13 amino acids which projects ~20 A from the core, and the flexible stem region between the base and the crown (7, 8). The epitopes of most known human anti-V3 mAbs have been mapped to the crown region of V3. Many of these mAbs have been carefully characterized by functional and structural methods. Recent structural studies have demonstrated that although the crown often forms a β-hairpin structure, it can be further divided into three distinct subregions: the band, the circlet, and the arch (8). The arch at the center of the V3 sequence contains the highly conserved 4-residue motif of gp120 residues 312–315, often composed of the sequence GPGR for clade B or GPGQ for nonclade B viruses. The circlet at the middle of the crown has a hydrophobic face and a hydrophilic face; the hydrophobic face contains two highly conserved isoleucine residues (Ile307 and Ile309). The band consists of the often positively charged residues 304 and 305 at the N-terminus and the highly conserved Tyr318 at the C-terminus. Among these subregions of V3 are four conserved structural elements: the arch, the band, the hydrophobic face of the circlet, and the peptide backbone. Anti-V3 antibodies that target these conserved structural elements are broadly reactive (8). Structural studies have also revealed that there are two general modes of antigen recognition for the human V3 mAbs: the ladle mode and the cradle mode. The ladle mode, typified by mAb 447–52D, is one where the antigen binding site is shaped like a soup ladle (9). The bowl of the ladle binds the arch of the V3 crown while the handle, formed by a long CDRH3 in the case of 447–52D, interacts with the N-terminal half of the V3 crown by main-chain interactions. Conversely, the cradle-binding mode, typified by mAbs 2219, is one where the antigen binding site is shaped like a cradle and the V3 crown sinks into the cradle, often burying the hydrophobic face of the circlet (8). Although mAb 447–52D (IgG3, λ) has somatic mutation frequencies of only 5.4% and 2.5% for VH and VL, respectively (10), it harbors a sophisticated antigen binding site. 447–52D has a long CDRH3 of 20 amino acids (Kabat definition) that forms a β-hairpin structure standing tall at one side of the antigen binding site (the handle of the ladle). The antigen binding side β strand of the CDRH3, decorated with 5 consecutive tyrosines (residues 100G–100K), makes main chain interactions with the N-terminal strand of the V3 crown. There is a shallow pocket at the base of CDRH3 that can be considered as the bowl of the ladle. On one side of the bowl, two tryptophans, residue 91 of the light chain (TrpL91) and TrpL96, form a wall that packs against the GPG turn of the V3 arch. On the other side of the bowl, TyrH100J and TrpH33 of the heavy chain form perfect π–cation stacking geometry that sandwiches the guanidinium group of Arg315 of V3. In addition, the side chain of Arg315 of V3 forms a salt bridge with the side chain of AspH95. This highly specific binding of the Arg315 side chain with a π–cation stacking and a salt bridge has led to speculation that Arg315 is the signature motif of the epitope of 447–52D (11). This might be the cause of 447–52D’s preference for neutralizing clade B viruses over nonclade B viruses (12). Although investigated by us and other groups, analysis of the structure-function relationship of the antigen binding site of 447–52D still presents unanswered questions. For example, although the crystal structures of the antigen binding fragments (Fabs) of 447–52D in complex with V3 peptides of clade B and nonclade B sequences have been obtained (9, 10), the role of the C-terminal region of V3 crown hairpin in the antigen antibody interaction was not clear because the residues after 316 had poor electron densities. The C-terminus was later extended to residue 319 in another crystal structure (13), but the diffraction data set was epitaxially twinned and the structure was not sufficiently refined. There are also some inaccuracies of the placement of key residue Arg315 of the V3 loop and water molecules within the antigen binding site (9, 13). Most importantly, the contribution to antigen binding of the individual residues cannot be determined from the structure alone because residues at the antigen–antibody interface do not contribute equally to the affinity and neutralization function of the antibody. Instead, studies have indicated that the residue’s contribution to the antibody function is not uniformly distributed along the binding interface; rather, the majority of the contribution is often localized to a subset of residues (14–16). To study the contribution of individual residues, a structure-guided computational approach has been used (17). However, it cannot accurately predict the affinity (kD) and Gibbs free binding energy (ΔG) from atomic structures. Purely functional studies are also limited in that they lack the precision at the single residue level (12, 18). Therefore, the best approach is to interrogate the contribution of individual residues at the molecular level by sensitive binding assays guided by computational and structural studies. SPR (19), ELISA (20), and FRET(21) assays have also been used to measure affinity with high sensitivity, but these techniques cannot determine a complete thermodynamic signature. Isothermal titration calorimetry (ITC) is a unique technique that can not only provide the accurate measurement of the binding affinities but also sensitively quantitate the thermodynamic signatures of individual residues at a specific temperature (22, 23). Here we present a detailed interrogation of the antigen binding site of 447–52D using a combination of mutagenesis, neutralization assays using pseudoviruses, and determination of affinity by ITC.